Literature DB >> 32506871

Sepsis-induced cardiac dysfunction: a review of pathophysiology.

Reverien Habimana1, Insu Choi2, Hwa Jin Cho3, Dowan Kim4, Kyoseon Lee4, Inseok Jeong4.   

Abstract

It is well known that cardiac dysfunction in sepsis is associated with significantly increased mortality. The pathophysiology of sepsis-induced cardiac dysfunction can be summarized as involving impaired myocardial circulation, direct myocardial depression, and mitochondrial dysfunction. Impaired blood flow to the myocardium is associated with microvascular dysfunction, impaired endothelium, and ventriculo-arterial uncoupling. The mechanisms behind direct myocardial depression consist of downregulation of β-adrenoceptors and several myocardial suppressants (such as cytokine and nitric oxide). Recent research has highlighted that mitochondrial dysfunction, which results in energy depletion, is a major factor in sepsis-induced cardiac dysfunction. Therefore, the authors summarize the pathophysiological process of cardiac dysfunction in sepsis based on the results of recent studies.

Entities:  

Keywords:  heart; mitochondria; pathophysiology; sepsis

Year:  2020        PMID: 32506871     DOI: 10.4266/acc.2020.00248

Source DB:  PubMed          Journal:  Acute Crit Care        ISSN: 2586-6052


  11 in total

Review 1.  Vital signs as physiomarkers of neonatal sepsis.

Authors:  Brynne A Sullivan; Karen D Fairchild
Journal:  Pediatr Res       Date:  2021-09-07       Impact factor: 3.756

2.  Diminazene aceturate mitigates cardiomyopathy by interfering with renin-angiotensin system in a septic rat model.

Authors:  Zhaoqing Lu; Di Wu; Zheng Wang; Hanyu Zhang; Yufan Du; Guoxing Wang
Journal:  BMC Pharmacol Toxicol       Date:  2022-07-04       Impact factor: 2.605

Review 3.  An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach.

Authors:  Behnaz Mokhtari; Rana Yavari; Reza Badalzadeh; Ata Mahmoodpoor
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-06-06       Impact factor: 2.585

Review 4.  Sepsis-Pathophysiology and Therapeutic Concepts.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Front Med (Lausanne)       Date:  2021-05-14

5.  High serum nitrates levels in non-survivor COVID-19 patients.

Authors:  L Lorente; F Gómez-Bernal; M M Martín; J A Navarro-Gonzálvez; M Argueso; A Perez; L Ramos-Gómez; J Solé-Violán; J A Marcos Y Ramos; N Ojeda; A Jiménez
Journal:  Med Intensiva (Engl Ed)       Date:  2020-11-10

6.  Exosomes Derived from miR-146a-5p-Enriched Mesenchymal Stem Cells Protect the Cardiomyocytes and Myocardial Tissues in the Polymicrobial Sepsis through Regulating MYBL1.

Authors:  Chun Liu; Jianhua Xue; Bo Xu; Aixian Zhang; Lili Qin; Jiajia Liu; Yang Yang
Journal:  Stem Cells Int       Date:  2021-10-15       Impact factor: 5.443

7.  Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis.

Authors:  Dong-Hua Liu; Yi-Le Ning; Yan-Yan Lei; Jing Chen; Yan-Yan Liu; Xin-Feng Lin; Zhong-Qi Yang; Shao-Xiang Xian; Wei-Tao Chen
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

8.  High serum nitrates levels in non-survivor COVID-19 patients.

Authors:  L Lorente; F Gómez-Bernal; M M Martín; J A Navarro-Gonzálvez; M Argueso; A Perez; L Ramos-Gómez; J Solé-Violán; J A Marcos Y Ramos; N Ojeda; A Jiménez
Journal:  Med Intensiva (Engl Ed)       Date:  2022-03

9.  Expression of Peripheral Blood DCs CD86, CD80, and Th1/Th2 in Sepsis Patients and Their Value on Survival Prediction.

Authors:  Ke Du; Shaobo Hao; Heyun Luan
Journal:  Comput Math Methods Med       Date:  2022-03-09       Impact factor: 2.238

10.  Recombinant Activated Protein C (rhAPC) Affects Lipopolysaccharide-Induced Mechanical Compliance Changes and Beat Frequency of mESC-Derived Cardiomyocyte Monolayers.

Authors:  Aysegül Temiz Artmann; Eylem Kurulgan Demirci; Ipek Seda Fırat; Hakan Oflaz; Gerhard M Artmann
Journal:  Shock       Date:  2022-04-01       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.